Skip to main content
Clinical Trials/NCT01303627
NCT01303627
Completed
Phase 4

The Effects of Maintenance a Remifentanil Infusion on the Hemodynamic Variables and Recovery Quality

Diskapi Teaching and Research Hospital1 site in 1 country42 target enrollmentFebruary 2011

Overview

Phase
Phase 4
Intervention
remifentanil
Conditions
Urinary Tract Problem
Sponsor
Diskapi Teaching and Research Hospital
Enrollment
42
Locations
1
Primary Endpoint
Smooth cLMA Removal Condition (Score 1)
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The effect of maintenance remifentanil infusion with target controlled infusion during laryngeal mask airway removal on hemodynamic parameters and emergence quality is going to be investigated.

Detailed Description

In all patients (control group and remifentanil group induction of anesthesia will be achieved with desflurane and remifentanil.Anesthesia will be maintained with remifentanil (1-4 ng/mL) by TCI target controlled infusion, and desflurane . Throughout the surgery hemodynamic parameters are going to be recorded. As soon as the surgery has been finished, in control group remifentanil infusion and desflurane inhalation is going to be stopped.In remifentanil group,desflurane inhalation is going to be stopped and remifentanil infusion will be maintained until the removal of LMA. During the emergence period the time of eye opening, hemodynamic parameters and emergence quality (score 1-2)are going to be recorded.

Registry
clinicaltrials.gov
Start Date
February 2011
End Date
April 2011
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

derya özkan

MD consultant

Diskapi Teaching and Research Hospital

Eligibility Criteria

Inclusion Criteria

  • ASA I-II status
  • aged 18-60 years old
  • presenting for ureterorenoscopy

Exclusion Criteria

  • history of hypertension
  • asthma and chronic obstructive lung disease
  • recent respiratory tract infections

Arms & Interventions

ultiva,remifentanil,opioid,analgesic

Remifentanil:1.5ng/ml remifentanil infusion maintained at the end of the surgery

Intervention: remifentanil

Outcomes

Primary Outcomes

Smooth cLMA Removal Condition (Score 1)

Time Frame: At the end of the surgery

cLMA removal was accepted as successful (score 1) if none of the complications coughing, teeth clenching, gross purposeful movements, breath holding, laryngospasm, and desatura- tion to SpO2\\90% was observed. If any of these compli- cations was observed it was regarded as unsuccessful (score 2)

Study Sites (1)

Loading locations...

Similar Trials